Aventura Private Wealth’s Soleno Therapeutics SLNO Stock Holding History

Aventura Private Wealth’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$1K	–	1014
2026 Q1	$1K	Hold	30	–	–	﹤0.01%	798
2025 Q4	$1.39K	Hold	30	–	–	﹤0.01%	719
2025 Q3	$2.03K	Hold	30	–	–	﹤0.01%	675
2025 Q2	$2.51K	Hold	30	–	–	﹤0.01%	604
2025 Q1	$2.14K	Hold	30	–	–	﹤0.01%	599
2024 Q4	$1.35K	Buy	+30	New	+$1.55K	﹤0.01%	616

Aventura Private Wealth's SLNO Position: Q2 2026 in Review

Aventura Private Wealth sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 30 shares — an estimated $1K sold.

Aventura Private Wealth first reported a position in SLNO in Q4 2024 and held it in 6 quarters. The position peaked at $2.51K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Aventura Private Wealth reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Aventura Private Wealth sold 30 Soleno Therapeutics shares in Q2 2026, an estimated $1K.
Aventura Private Wealth first reported a position in Soleno Therapeutics in Q4 2024 and held it in 6 quarters.
Aventura Private Wealth's Soleno Therapeutics position peaked at $2.51K in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.